Publications by authors named "M Telko"

The impact of formulation variables on aerodynamic and electrostatic properties of dry powder aerosol particles is of great importance to the development of efficient and reproducible inhaler products. Systematic evaluation requires a well-designed series of experiments using appropriate methods. A factorial experimental design was employed.

View Article and Find Full Text PDF

Novel treatments for multidrug-resistant tuberculosis (MDR-TB), extensively drug-resistant tuberculosis (XDR-TB), or latent TB are needed urgently. Recently, we reported the formulation and characterization of the nitroimidazo-oxazine PA-824 for efficient aerosol delivery as dry powder porous particles and the subsequent disposition in guinea pigs after pulmonary administration. The objective of the present study was to evaluate the effects of these PA-824 therapeutic aerosols on the extent of TB infection in the low-inoculum aerosol infection guinea pig model.

View Article and Find Full Text PDF

The purpose of these studies was to investigate the ability of surface energy measurements and rates of mixing in dry powder inhaler (DPI) formulations to predict aerosol dispersion performance. Two lactose carrier systems comprising either spray-dried or milled particles were developed such that they had identical physical characteristics except for surface morphology and surface energies avoiding confounding variables common in other studies. Surface energy measurements confirmed significant differences between the powder systems.

View Article and Find Full Text PDF

Inverse gas chromatography (IGC) has been employed as a research tool for decades. Despite this record of use and proven utility in a variety of applications, the technique is not routinely used in pharmaceutical research. In other fields the technique has flourished.

View Article and Find Full Text PDF
Article Synopsis
  • Capreomycin is being re-evaluated for treating multidrug-resistant tuberculosis (MDR-TB) using low-density porous sulfate particles designed for effective pulmonary delivery.
  • Research aims to assess the pharmacokinetics of these particles and their effectiveness in reducing bacterial loads in a guinea pig model of TB.
  • Results indicate that the newly formulated capreomycin particles significantly decreased bacterial burdens and improved drug bioavailability, suggesting a potential reduction in side effects if adopted for human use.
View Article and Find Full Text PDF